Comprehensive Investigation of the Molecular Defect in vif -Deficient Human Immunodeficiency Virus Type 1 Virions
- 15 May 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (10) , 5810-20
- https://doi.org/10.1128/jvi.77.10.5810-5820.2003
Abstract
Replication of human immunodeficiency virus type 1 (HIV-1) in primary blood lymphocytes, certain T-cell lines (nonpermissive cells), and most likely in vivo is highly dependent on the virally encoded Vif protein. Evidence suggests that Vif acts late in the viral life cycle during assembly, budding, and/or maturation to counteract the antiviral activity of the CEM15 protein and possibly other antiviral factors. Because HIV-1 virions produced in the absence of Vif are severely restricted at a postentry, preintegration step of infection, it is presumed that such virions differ from wild-type virions in some way. In the present study, we established a protocol for producing large quantities of vif -deficient HIV-1 (HIV-1/Δ vif ) from an acute infection of nonpermissive T cells and performed a thorough examination of the defect in these virions. Aside from the expected lack of Vif, we observed no apparent abnormalities in the packaging, modification, processing, or function of proteins in Δ vif virions. In addition, we found no consistent defect in the ability of Δ vif virions to perform intravirion reverse transcription under a variety of assay conditions, suggesting that the reverse transcription complexes in these particles can behave normally under cell-free conditions. Consistent with this finding, neither the placement of the primer tRNA3Lys nor its ability to promote reverse transcription in an in vitro assay was affected by a lack of Vif. Based on the inability of this comprehensive analysis to uncover molecular defects in Δ vif virions, we speculate that such defects are likely to be subtle and/or rare.Keywords
This publication has 48 references indexed in Scilit:
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Identification of a host protein essential for assembly of immature HIV-1 capsidsNature, 2002
- Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed GagJournal of Virology, 2001
- The Tyrosine Kinase Hck Is an Inhibitor of HIV-1 Replication Counteracted by the Viral Vif ProteinPublished by Elsevier ,2001
- HIV-1 RNA Editing, Hypermutation, and Error-Prone Reverse TranscriptionScience, 2001
- Generation of G-to-A and C-to-U Changes in HIV-1 Transcripts by RNA EditingScience, 2000
- A Structured RNA Motif Is Involved in Correct Placement of the tRNA 3 Lys Primer onto the Human Immunodeficiency Virus GenomeJournal of Virology, 2000
- Peptides derived from HIV-1 vif: a non-substrate based novel type of HIV-1 protease inhibitorsJournal of Molecular Biology, 1999
- Molecular Beacons: Probes that Fluoresce upon HybridizationNature Biotechnology, 1996
- HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulatorCell, 1995